2nd Generation Packaging Mix

Cat. No.

LV003

Unit

200 µl

Price

$293.00

Cat. No.

LV003

Name

2nd Generation Packaging Mix

Unit

200 µl

Description

abm’s Second Generation lentivirus packaging plasmid mix offers a high-safety, high-efficiency solution for lentivirus production. This system requires three plasmids for viral particle production:

1) Transfer Plasmid containing your gene of interest.
2) Packaging Plasmid containing structural proteins Gag, Pol, Tat, Rev.
3) Envelope Plasmid containing transmembrane glycoprotein VSV-G.

The ready-to-use 2nd Generation Packaging Mix combines optimized Packaging and Envelope Plasmids for high viral titers, enhanced biosafety and reliable gene delivery performance.

Product Mix Component	Vector Map
pLenti-P2A	Click to view
pLenti-P2B	Click to view

Applications

Storage Condition

-20°C or below.

Promotions

Bundle up, save more! These cost-saving bundles combine our best-selling Lentivirus Packaging Mix with reagents for transfection, virus titration and transduction!

Material Citation

If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LV003

Datasheet

LV003 Datasheet

Search CoA here

MSDS

Plasmid MSDS

Supporting Protocol

Other

	Is it possible to propagate the packaging plasmids from this product mix?
	No, it is not possible to grow up the plasmids from the product.

	What is the concentration of your packaging plasmid mixes?
	The packaging plasmid mixes are offered at 0.5 µg/µl.

	What viral titers can be achieved using abm's second and third generation packaging mixes?
	Both our second (Cat. No. LV003) and third (Cat. No. LV053) generation packaging mixes can achieve a titer of 10^6 IU/ml from the crude viral supernatant (without concentration/filtration) using HEK293T cells.

	What generation does abm use for their lentiviral expression/transfer vectors?
	All lentiviral expression vectors marketed by abm are third generation with a chimeric RSV promoter upstream of the 5’ LTR.

	What is the difference between the lentivirus second and third generation systems?
	The second generation system uses 3 plasmids (transfer, packaging, envelope), while the third generation uses 4 plasmids (transfer, packaging#1, packaging#2, envelope), separating Rev into its own plasmid for enhanced biosafety.

	Which system is safer, second or third generation?
	The third generation system offers a higher biosafety level due to further separation of viral genes on additional plasmids thus further minimizing recombination risk.

	Are abm’s lentiviral vectors TAT-dependent or TAT-independent?
	All of abm’s expression/transfer lentiviral vectors are TAT-independent.

	What cell line should I use for lentivirus production?
	We recommend using HEK293T cell line due to its high transfection efficiency and virus yield.

Do you recommend using second or third generation lentivirus packaging mix?

abm's lentiviral vectors are compatible with second and third generation packaging systems. We recommend the Second Generation Packaging Mix (Cat. No. LV003) for users who want to achieve higher titer lentivirus as only 3 plasmids are required for virus production. We also recommend the Third Generation Packaging Mix (Cat. No. LV053) for users concerned with virus biosafety, as the viral packaging elements are further split into 4 plasmids thus reducing probably of recombination into wild type virus.

Is 2nd Generation or 3rd Generation packaging mix better for lentivirus production?

The 2^nd Generation Packaging System Mix is recommended unless your facility requires 3^rd Generation Packaging Systems for stricter safety regulations.

Feature	2^nd Generation Packaging System Mix	3^rd Generation Packaging System Mix
Transfer Plasmid	Can package 2^nd or 3^rd Generation transfer plasmids (Tat dependent or independent)	Can ONLY package 3^rd Generation transfer plasmids (Tat independent)
Packaging Plasmids	One plasmid encoding Gag, Pol, Rev, and Tat	Two plasmids: one encoding Gag and Pol, and one encoding Rev
Envelope Plasmid	Interchangeable: usually encodes for VSV-G	Interchangeable: usually encodes for VSV-G
Safety	Safe. Replication incompetent: Uses 3 separate plasmids encoding various HIV genes.	Safer. Replication incompetent and always self inactivating: Uses 4 plasmids instead of 3 and eliminates the requirement for Tat.
Recombinant Virus Yield	Higher yields than 3^rd Generation due to fewer plasmids (3) required to be transfected	Lower yields than 2^nd Generation due to more plasmids (4) required to be transfected

Jin, Q et al. "Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells" PLoS ONE 8(6):e66439 (2013). DOI: doi:10.1371/journal.pone.0066439.
Pae, EK;Kim, G;, et al. "Insulin production hampered by intermittent hypoxia via impaired zinc homeostasis" PLoS ONE 9-2:e90192 (2014). PubMed: 24587273.
Jin, Q;Liu, G;Domeier, PP;Ding, W;Mulder, KM;, et al. "Decreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells" PLoS ONE 8-6:e66439 (2013). PubMed: 23755307.
Taylor, HE et al. "The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection" J. Virol. 1:592-603 (2014). DOI: 10.1128/JVI.02828-13. PubMed: 24173214. Application: Viral Packaging.
Morgan, S. "PKA as the Effector of Beta-2-Adrenoreceptor Signaling Regulating Airway Smooth Muscle Relaxation" Thesis : (2013). Application: Viral Packaging.
Li, FY et al. "Second messenger role for Mg2+ revealed by human T-cell immunodeficiency" Nature 475:471 - 6 (2011). DOI: 10.1038/nature10246. PubMed: 21796205. Application: Transfection.
George, R et al. "A SHORT INTERFERING RNA MOLECULAR BEACON FOR THE ATTENUATION OF MYCOBACTERIAL INFECTION" American Journal of Biochemistry and Biotechnology 10:40-49 (2014). DOI: 10.3844/ajbbsp.2014.40.49. Application: Viral Packaging.
Pae, E. K. et al. "Insulin Production Hampered by Intermittent Hypoxia Via Impared Zinc Homeostasis " PLoS One 2:e90192 (2014). DOI: 10.1371/journal.pone.0090192. PubMed: 24587273. Application: Lentivirus Production .
Zhang, J et al. "The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line" Tumour Biol. :1-9 (2015). PubMed: 26586397.
Morgan, SJ et al. "β-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent" J Biol Chem 289(33):23065-74 (2014). DOI: 10.1074/jbc.M114.557652. PubMed: 24973219.
Juang, YL et al. "PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer" Mol Carcinog : (2016). DOI: 10.1002/mc.22465. PubMed: 26824226.
Nangami, et al. "Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas" Cancer Medicine : (2016). DOI: 10.1002/cam4.940. Application: Knockdown of Cell Line.
Juang, YL et al. "PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer" Molecular Carcinogenesis 55.12:2247–2259 (2016). DOI: 10.1002/mc.22465. Application: Packaging.
Zhang, et al. "The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line" Tumour Biology 37.5:5847 (2016). DOI: 10.1007/s13277-015-4405-z. Application: Generation of lentiviral vectors.
Geekiyanage, H et al. "MiR-31 and miR-128 regulates poliovirus receptor-related 4" Mol Oncol 9:1387-1403 (2016). DOI: 10.1016/j.molonc.2016.07.007.
Cho, I. S., Gupta, P., Mostafazadeh, N., Wong, S. W., Saichellappa, S., Lenzini, S., Peng, Z., & Shin, J. (2022). Deterministic Single Cell Encapsulation in Asymmetric Microenvironments to Direct Cell Polarity. Advanced Science, 10(3). https://doi.org/10.1002/advs.202206014
Li, H., Kanamori, Y., & Moroishi, T. (2024). Cell attachment defines sensitivity to cold stress via the Hippo pathway. Biochemical and Biophysical Research Communications, 730, 150373. https://doi.org/10.1016/j.bbrc.2024.150373
Wang, L., Huang, M., Zhang, S., Yang, Y., & Huang, B. (2023). NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma. https://doi.org/10.21203/rs.3.rs-3412110/v1
Janneh, A. H., Kassir, M. F., Atilgan, F. C., Lee, H. G., Sheridan, M., Oleinik, N., ... & Ogretmen, B. (2022). Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Reports, 41(10), 111742. https://doi.org/10.1016/j.celrep.2022.111742
Lenzini, S., Bargi, R., Chung, G., & Shin, J.-W. (2020). Matrix mechanics and water permeation regulate extracellular vesicle transport. Nature Nanotechnology, 15(3), 217–223. https://doi.org/10.1038/s41565-020-0636-2
Zhou, N., Tian, Y., Wu, H., Cao, Y., Li, R., Zou, K., Xu, W., & Lu, L. (2022). Protective Effect of Resveratrol on Immortalized Duck Intestinal Epithelial Cells Exposed to H2O2. Molecules, 27(11), 3542. https://doi.org/10.3390/molecules27113542
He, P., Jiang, F., Wu, L.-F., Zhou, X., Lei, S.-F., & Deng, F.-Y. (2021). Why SNP rs3755955 is associated with human bone mineral density? A molecular and cellular study in bone cells. Molecular and Cellular Biochemistry, 477(2), 455–468. https://doi.org/10.1007/s11010-021-04292-1
Habib, K., Bishayee, K., Kang, J., Sadra, A., & Huh, S.-O. (2022). RNA Binding Protein Rbms1 Enables Neuronal Differentiation and Radial Migration during Neocortical Development by Binding and Stabilizing the RNA Message for Efr3a. Molecules and Cells, 45(8), 588–602. https://doi.org/10.14348/molcells.2022.0044
Papes, F., Camargo, A. P., de Souza, J. S., Carvalho, V. M. A., Szeto, R. A., LaMontagne, E., Teixeira, J. R., Avansini, S. H., Sánchez-Sánchez, S. M., Nakahara, T. S., Santo, C. N., Wu, W., Yao, H., Araújo, B. M. P., Velho, P. E. N. F., Haddad, G. G., & Muotri, A. R. (2022). Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29942-w
Wang, Z., Snyder, M., Kenison, J. E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A., Monti, S., & Sherr, D. H. (2020). How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression. International Journal of Molecular Sciences, 22(1), 387. https://doi.org/10.3390/ijms22010387
Pinto, C., Slavic-Obradovic, K., Fürweger, D., Thaler, B., Souabni, A., Carotta, S., Aichinger, M., Reiser, U., Impagnatiello, M. A., & Tirapu, I. (2023). Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics. IScience, 26(4), 106381. https://doi.org/10.1016/j.isci.2023.106381
HU, N., ZHANG, S., JIN, A., GUO, L., QU, Z., & WANG, J. (2022). SPINK1 contributes to proliferation and clonal formation of HT29 cells through Beclin1 associated enhanced autophagy. Oncology Research, 30(2), 89–97. https://doi.org/10.32604/or.2022.027058
Zhang, S., Lv, C., Niu, Y., Li, C., Li, X., Shang, Y., Zhang, Y., Zhang, Y., Zhang, Y., & Zeng, Y. (2023). RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA. Cell Death & Disease, 14(2). https://doi.org/10.1038/s41419-023-05627-0
Zhu, S., Al-Mathkour, M., Cao, L., Khalafi, S., Chen, Z., Poveda, J., Peng, D., Lu, H., Soutto, M., Hu, T., McDonald, O. G., Zaika, A., & El-Rifai, W. (2023). CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis. Cell Reports, 42(1), 112005. https://doi.org/10.1016/j.celrep.2023.112005
Suzuki, H., Nagase, S., Saito, C., Takatsuka, A., Nagata, M., Honda, K., Kaneda, Y., Nishiya, Y., Honda, T., Ishizaka, T., Nakamura, K., Nakada, T., Abe, Y., & Agatsuma, T. (2024). Data from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models. https://doi.org/10.1158/1535-7163.c.7104454.v1
Cao, L., Lin, G., Fan, D., Weng, K., Chen, Y., Wang, J., Li, P., Zheng, C., Huang, C., & Xie, J. (2024). NUAK1 activates STAT5/GLI1/SOX2 signaling to enhance cancer cell expansion and drives chemoresistance in gastric cancer. Cell Reports, 43(7), 114446. https://doi.org/10.1016/j.celrep.2024.114446